The Medical Research Commercialisation Fund Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 3
- Investments
- 34
- Portfolio
- 23
- Exits
- 5
The Medical Research Commercialisation Fund General Information
Description
The Medical Research Commercialisation Fund is a venture capital firm based in Melbourne, Australia.
Contact Information
Website
www.mrcf.com.au
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Level 9, 31 Queen Street
- Melbourne, Victoria 3000
- Australia
+61 (03) 0000 0000
The Medical Research Commercialisation Fund Investments (34)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Amaroq Therapeutics | 07-Jul-2021 | Early Stage VC | 0000 | Biotechnology | Out of Business | |
| 000000 000000000 | 22-Jun-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 000 00000000000 | 15-Jun-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 000000 000000 | 27-May-2021 | 0000 00000 | 00.000 | Drug Discovery | Generating Revenue | |
| 00000 00000000000 | 22-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000000000 0000 00.0 |
| 000000 000000 | 10-Mar-2020 | 00 000000000 | 0000 | Drug Discovery | Generating Revenue | |
| 00000000 000000000 | 07-Feb-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | |
| 0000000 0000000000 | 18-Dec-2019 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 00000000000 0000 00.0 |
| Denteric | 26-Sep-2019 | Early Stage VC | 0000 | Drug Discovery | Product Development | 00000000000 0000 00.0 |
| EBR Systems | 27-Aug-2019 | Later Stage VC | 0000 | Therapeutic Devices | Generating Revenue/Not Profitable | 00000000000 0000 00.0 |
The Medical Research Commercialisation Fund Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Amaroq Therapeutics | 06-Jan-2022 | Out of Business | |
| 000 0000000 | 24-Nov-2021 | 000 | 000.00 |
| 000000000 | 30-Apr-2019 | 000 00 00000000 | |
| Otifex Therapeutics | 20-Jul-2017 | Merger/Acquisition | |
| GI Therapies | Secondary Transaction - Private |
The Medical Research Commercialisation Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialThe Medical Research Commercialisation Fund Team (2)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alan Stockdale | Emeritus Advisor | Melbourne, Australia | |||
| Christopher Nave Ph.D | Chief Executive Officer | 00 | 0 | 0 | Melbourne, Australia |
The Medical Research Commercialisation Fund Co-Investors (32)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Brandon Capital Partners | 15 | 0 | 0 |
|
|
| Uniseed | 0 | 0 |
|
|
|
| Australian Government (Landing Pads) | 0 | 0 |
|
|
|
| Stoic Venture Capital | 0 | 0 |
|
|
|
| Goodwin | 0 | 0 |
|
|